Client-specific scope reductions in life sciences
A large life sciences client abruptly reduced scope, causing revenue decline. Recovery depends on client's future investment decisions.
high · management_commentaryTata Consultancy Services Ltd — Q2 FY25
TCS reported Q2 FY25 revenue of INR 64,259 crore, up 7.6% YoY, with constant currency growth of 5.5%.
neutral
medium
✓ Verified against BSE filing
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
Prolonged weakness in telecom and manufacturing
Telecom and manufacturing verticals face structural headwinds; telecom due to CapEx caution, manufacturing due to labor and supply chain issues.
medium · management_commentaryBSNL deal tapering could create revenue gap
The BSNL deal revenue is at peak and expected to taper after Q3, potentially creating a growth headwind in H2.
medium · analyst_questionMargin pressure from growth market investments
Growth markets have lower margins; scaling them may pressure overall margins until volumes improve.
medium · analyst_question